MEHP|CAS 4376-20-9|DC Chemicals

Cas No.:	4376-20-9
Chemical Name:	2-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid
Synonyms:	2-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid;Mono-2-ethylhexyl Phthalate;1,2-Benzenedicarboxylic acid, 1-(2-ethylhexyl) ester;2-(2-ethylhexoxycarbonyl)benzoic acid;Monoethylhexyl phthalate (mEHP);rac Mono(ethylhexyl) Phthalate;RAC MONO(ETHYLHEXYL) PHTHALATE,COLORLESS OIL;2-ethylhexyl hydrogen phthalate;Mehp;Mono(2-ethylhexyl) phthalate;PHTHALIC ACID MONO-2-ETHYLHEXYL ESTER;Mono(2-ethylhexyl)phthalate;Monoethylhexyl phthalate;Mono-(2-ethylhexyl)phthalate;(2-Ethylhexyl) hydrogen phthalate;BAR 1;1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester;Phthalate, mono(2-ethylhexyl);Monoethylhexyl phthalic acid;Phthalic aci;mono(ethylhexyl) phthalate;Monoethylhexyl
SMILES:	O(C(C1=C([H])C([H])=C([H])C([H])=C1C(=O)O[H])=O)C([H])([H])C([H])(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
Formula:	C₁₆H₂₂O₄
M.Wt:	278.3435
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:	MEHP (Phthalic acid mono-2-ethylexyl ester) is a competitive inhibitor of CYP2C9 with IC50 of 6.37 μM.
References:	[1]. Bai J, et al. Mono-2-ethylhexyl phthalate induces the expression of genes involved in fatty acid synthesis in HepG2 cells. Environ Toxicol Pharmacol. 2019 Jul;69:104-111. [2]. Chauvigné F, et al. Mono-(2-ethylhexyl) phthalate directly alters the expression of Leydig cell genes and CYP17 lyase activity in cultured rat fetal testis. PLoS One. 2011;6(11):e27172.

MSDS

Cat. No.	Product name	Field of application
DC72892	MEHP	MEHP (Phthalic acid mono-2-ethylexyl ester) is a competitive inhibitor of CYP2C9 with IC50 of 6.37 μM.
DC70373	DX314	DX314 is a potent, specific CYP26B1 inhibitor with IC50 of 108 nM, >15-fold selectivity over CYP26A1.DX314 potentiates all-trans-RA (atRA) gene expression effects in healthy and diseased reconstructed human epidermis (RHE).DX314 potentiates the effects of atRA on the expression and localization of keratin 10 (KRT10), protects barrier function in RHE.DX314 reduces comedonal number, induces epidermal thickening, and increases comedonal profile, while having no effect on transepidermal water loss (TEWL) in treated rhino mice.
DC70372	DX308	DX-308 is a potent, selective dual CYP26A1/B1 inhibitor and retinoic acid metabolism blocking agent.DX308 does not interact with off‐target nuclear receptors or CYP450s, is not genotoxic, and is stable in skin, despite vigorous hepatic metabolism.Topical DX308 induces comedolysis and epidermal thickening without apparent adverse effects in vivo.DX308 shows potent modulation of retinoid‐responsive genes by DX308 in both healthy and keratinization disorder keratinocytes (KCs).DX 308 may present an improved therapeutic alternative for the treatment of keratinization disorders and other retinoid‐responsive skin ailments.
DC50205	Abiraterone decanoate	Abiraterone decanoate is a potent Abiraterone prodrug. Abiraterone decanoate provide a controlled release of Abiraterone and long-acting CYP17 inhibition with intramuscular (IM) delivery.
DC11329	Fadrozole (hydrochloride)	Fadrozole is a non-steroidal aromatase inhibitor (IC50s = 5 and 1.4 nM for human placental and rat ovarian microsomal aromatase, respectively).